Introduction
============

Peroxisome-proliferator-activated receptors (PPARs) are ligand-activated nuclear transcription factors that function as key regulators of lipid metabolism.[@b1-nmi-7-2014-029],[@b2-nmi-7-2014-029] Long-chain fatty acids, in particular polyunsaturated fatty acids (PUFA) and their metabolites, have been shown to be potent endogenous ligands of PPARs.[@b3-nmi-7-2014-029]--[@b7-nmi-7-2014-029] PPARs bind to their target DNA sequences after formation of heterodimers with the retinoid X receptor (RXR) as a binding partner.[@b4-nmi-7-2014-029],[@b5-nmi-7-2014-029],[@b8-nmi-7-2014-029] Both the PPARs and RXR contain zinc finger structures in their DNA-binding domain that are essential for the binding of the nuclear response elements in the promoter region of their target genes.[@b9-nmi-7-2014-029]--[@b11-nmi-7-2014-029] Peroxisome-proliferator-activated receptor alpha (PPARα) is the major subtype in the liver, where it plays a central role in the regulation of fatty acid degradation.[@b1-nmi-7-2014-029]--[@b3-nmi-7-2014-029] *Pparα*-deficient mice exhibit defective mitochondrial fatty acid oxidation and ketone body production, and fatty livers in response to starvation.[@b12-nmi-7-2014-029]--[@b14-nmi-7-2014-029] Transcript levels of *Pparα* and of PPARα target genes encoding key enzymes of fatty acid oxidation, including the mitochondrial Δ[@b3-nmi-7-2014-029],Δ[@b2-nmi-7-2014-029]-enoyl-CoA-isomerase *(Eci1* or *Dci)* gene, have been reported to be depressed in the liver of Zn-deficient young rats.[@b15-nmi-7-2014-029],[@b16-nmi-7-2014-029] The enzyme Δ[@b3-nmi-7-2014-029],Δ[@b2-nmi-7-2014-029]-enoyl-CoA-isomerase (EC 5.3.3.8) is needed for the conversion of *3-cis-*and 3-*trans*-enoyl-CoA esters of unsaturated fatty acids (UFA) to the 2-*trans*-enoyl-CoA esters for continued degradation of unsaturated fatty acids in the β-oxidation cycle.[@b17-nmi-7-2014-029],[@b18-nmi-7-2014-029] PPARγ as a transcription factor regulates mainly adipocyte differentiation and lipid storage.[@b19-nmi-7-2014-029],[@b20-nmi-7-2014-029] *Pparγ*-mRNA levels of thoracic aorta have been found to be significantly higher in Zn-depleted mice than in Zn-adequate and Zn-supplemented animals.[@b21-nmi-7-2014-029]

The aim of our study was to investigate the impact of a moderate dietary Zn deficiency and a high intake of PUFA on the expression levels of *Pparα, Pparγ,* and *Eci1* in the liver of weanling rats. The dietary content of available carbohydrates was restricted to impose a distinct preponderance of fatty acids as energy source. Safflower (SF) oil was chosen as a source rich in PUFA, and cocoa butter (CB) as a fat source rich in saturated fatty acids.

Methods and Materials
=====================

Animals, experimental design, and diets
---------------------------------------

A total of 40 male Wistar rats (Harlan-Winkelmann, Borchen, Germany) with an initial live weight of 50.8 ± 0.2 g (mean ± SD) were randomly allocated to five treatment groups. They were fed one of four semi-synthetic diets that were supplemented with 7.0 or 50 mg zinc/kg as Zn sulfate. Both the low-Zn (LZ) and high-Zn (HZ) diets contained either 22% CB or 22% SF oil. The feeding protocol in the five groups was as follows: (1) LZ-CB, fed the LZ-CB diet free choice; (2) HZ-CBR, fed the HZ-CB diet in restricted amounts according to intake of the LZ-CB diet on the previous day; (3) LZ-SF, fed the LZ-SF diet free choice; (4) HZ-SFR, fed the HZ-SF diet in restricted amounts according to intake of the LZ-SF diet on the previous day; and (5) HZ-SF, fed the HZ-SF diet free choice. All animals had free access to demineralized water. They were housed individually in polycarbonate cages (stainless-steel metal grids) under controlled environmental conditions (22°C, 60% rel. humidity, 12-hour light--dark cycle, lights on at 7.00 hours). All experimental treatments of the rats followed established guidelines for the care and handling of laboratory animals. Approval was obtained by the Animal Protection Authority of the State (II 25.3-19c20/15c GI 19/3).

[Table 1](#t1-nmi-7-2014-029){ref-type="table"} presents the composition of the experimental diets. After preparation, they were stored at 4°C. All diets contained 3% soybean oil as a source of essential fatty acids, and 28% cellulose as a diluent to restrict the energy density to a level comparable with that in a similar previous study[@b22-nmi-7-2014-029] and in the AIN-93 diet for rodents.[@b23-nmi-7-2014-029] Using tabulated values of the dietary components,[@b24-nmi-7-2014-029] the metabolizable energy (ME) content of the diets was calculated as 15.7 kJ/g, fat accounting for 59% and carbohydrates (starch and sucrose) for 22% of the ME. According to analysis, Zn concentrations in the LZ-CB, LZ-SF, HZ-CB, and HZ-SF diets (five replicates per diet) averaged 7.4 (SD, 0.6), 7.4 (0.7), 50.0 (6.9), and 50.5 (3.1), respectively. Based on the fatty acid composition reported in food tables,[@b24-nmi-7-2014-029] UFA accounted for about 40 and 86%, and linoleic acid for about 8 and 72% of the total fatty acids in the CB and SF diets, respectively.

After four weeks, ending with a 10--12-hour overnight food withdrawal (starting at 23.30 hours), the animals were anesthetized in a carbon dioxide atmosphere. They were killed and exsanguinated by decapitation. Blood was collected in heparinized tubes to prepare plasma. Liver and right femur were immediately excised from the carcasses and weighed. A segment of the central liver lobe was removed under sterile conditions and frozen in liquid nitrogen for later RNA extraction. Tissues were stored at −80°C.

Analytical Methods
==================

Zinc concentrations
-------------------

Diet samples, liver samples, and femur bone were wet-ashed with 65% (w/v) HNO~3~ for 16 hours, and diluted with aqua bidest for Zn analysis by inductively coupled plasma atomic emission spectroscopy (Unicam, Type 701). Zn analyses were replicated at least twice per sample, and accuracy was checked by standard samples of known Zn content. Plasma Zn concentrations were determined by hydride atomic absorption spectrometry (PU 9400, Phillips, Kassel, Germany) after dilution with 0.1 M HCl (1:20, v/v).

Liver triglycerides and plasma β-hydroxybutyrate (BHB)
------------------------------------------------------

Hepatic triglyceride concentration was determined as described previously.[@b22-nmi-7-2014-029] Briefly, total lipids were extracted in hexane:isopropanol and analyzed for triglycerides by a colorimetric assay kit (Roche Diagnostics, Mannheim, Germany). The concentration of BHB in plasma of five animals per diet group was determined in duplicate by an assay kit (Autokit 3-HB; Wako Chemicals GmbH, Neuss, Germany).

Expression of the target genes in the liver
-------------------------------------------

Total RNA content was extracted from pooled liver samples (50 mg from two animals each, three separate pools per diet group) by the acid guanidinium thiocyanate--phenol--chloroform procedure.[@b25-nmi-7-2014-029] All steps were performed at +4°C under RNase-free conditions. Denatured RNA was sedimented by centrifugation (30 minutes, 14,000 × *g,* 2°C). Final RNA pellets were washed twice with 1 mL 70% (v/v) ethanol, vacuum-dried, dissolved in H~2~O-diethylpyrocarbonate (DEPC) solution, and stored in portions at −80°C.

RNA concentration was determined spectrometrically at 260 and 280 nm against H~2~O-DEPC. Purity of the RNA preparation was confirmed by gel electrophoresis and ethidium bromide staining. Two different commercial kits were used for the reverse transcription of the harvested liver RNA: kit A, RevertAid™ First-Strand cDNA Synthesis Kit (Fermentas GmbH, St. Leon-Rot, Germany), using the oligo(dT) 18-primer, and kit B, iScript™ cDNA Synthesis Kit (Bio-Rad Laboratories Inc., Hercules, CA, USA), using random hexamer primers. The procedural steps were performed according to the manufacturer's instructions. The amplification of the first-strand cDNA (2.0 μL) was performed in volumes of 50 μL, which contained 5.0 μL 10 × PCR buffer in 20 mM MgCl~2~ (Fermentas), 3.8 μL 2 mM dNTP mix (Fermentas), 1.0 U Taq polymerase (5 U/μL; Peqlab), 2.5 μL each for the specific forward and reverse primers (10 μM; MWG Biotech-AG), and 34.0 μL H~2~O-DEPC. The nucleotide sequences of the primer pairs were *Pparα* (accession number NM_013196, NCBI), forward 5′-acgatgctgtcctccttgat-3′, reverse 5′-cttcttgatgacctgcacga-3′; peroxisome-proliferator-activated receptor gamma (*Pparγ*) (NM_013124, NCBI), forward 5′-gagtctgtggggataaagcatc-3′, reverse 5′-gcgggaaggactttatgtatga-3′; mitochondrial short-chain enoyl-CoA isomerase (*Eci1,* synonym *Dci*) (X61184 or NM_017306, NCBI), forward 5′-caggataatggcggacaact-3′, reverse 5′-tacacgtgcagggacttctg-3′; and glycerol aldehyde-3-phosphate dehydrogenase (*Gapdh*) (NM_017008, NCBI), forward 5′-acgggaagctcactggcatg-3′, reverse 5′-ccaccaccctgttgctgtag-3′. The cDNA (in 2 μL containing about 1 μg for kit A and 0.7 μg for kit B) was amplified for 26--32 cycles (MyCycler, Bio-Rad Laboratories Inc.).

The PCR products were electrophoresed on 1.5% ethidium bromide agarose gel. A base pair standard (GeneRuler DNA Ladder Plus, Fermentas) was included in the gel electrophoresis to check the length of the fragments. The spots were documented by means of a ChemiImager with a CCD video system and AlphaEase imaging software (Central Biotechnology Unit of the Justus Liebig University, Giessen, Germany) and digitalized by the software package GelScan 5.1 (BioSciTec GmbH, Frankfurt am Main, Germany). The amount of mRNA of the target genes (background-corrected) was normalized to the *Gapdh*-mRNA content and expressed as relative units. The final data were expressed as a multiple of the lowest mean of the target gene to emphasize the differences in gene expression.

Statistical analyses
--------------------

The results of the five treatment groups were analyzed by one-way analysis of variance (ANOVA), using the IBM SPSS package, version 19 for Windows. Homogeneity of variance was verified by the Levene test. The Tukey HSD procedure was applied for post hoc comparisons among the five groups, the level of significance being set at *P* \< 0.05. Standard errors of the mean (SEM) are based on the residual error of one-way ANOVA. Gene transcription levels obtained by the two test kits (A and B) were averaged per liver pool sample before ANOVA, because both test kits delivered similar mean expression levels of the target genes as indicated by the Pearson's correlation coefficient (*Pparα*-mRNA*, r* = 0.95, *P* = 0.012; *Pparγ*-mRNA*, r* = 0.55, *P* = 0.334; *Eci1*-mRNA, *r* = 0.93, *P* = 0.021).

Results
=======

Food intake and growth of the animals
-------------------------------------

Food consumption in the three groups fed free choice was significantly affected by dietary Zn level and fat source (*P* \< 0.001), and averaged 391, 277, and 428 g in LZ-CB, LZ-SF, and HZ-SF, respectively, during the four-week period. Final body weights of the weanling rats fed the LZ-CB and LZ-SF diets remained 14 and 31%, respectively, below that of the animals offered the HZ-SF diet free choice (*P* \< 0.05; [Fig. 1](#f1-nmi-7-2014-029){ref-type="fig"}). Growth of the HZ-CBR and HZ-SFR groups, whose food allocation was restricted, was comparable to that of the animals fed the corresponding LZ diets free choice throughout the four-week period.

Zinc status
-----------

Both dietary Zn level and fat source markedly affected plasma and femur Zn concentrations, whereas liver Zn concentrations remained closely comparable among diet groups ([Table 2](#t2-nmi-7-2014-029){ref-type="table"}). Plasma Zn concentration of LZ-SF group was significantly lower than that of the LZ-CB group, and also significantly lower in the HZ-SFR than in the HZ-CBR group (*P* \< 0.05).

Plasma BHB and liver triglyceride concentrations
------------------------------------------------

Plasma BHB concentrations at the end of the four-week experiment were approximately twofold (*P* \< 0.05) lower in the HZ-CBR and HZ-SFR groups than in the three groups fed free choice ([Fig. 2](#f2-nmi-7-2014-029){ref-type="fig"}). Hepatic triglyceride (TAG) concentrations were not significantly altered by the dietary Zn supply ([Fig. 3](#f3-nmi-7-2014-029){ref-type="fig"}). Overall, the rats fed the SF diets displayed significantly higher TAG levels than those fed the CB diets (*P* \< 0.05).

Gene expression of *Pparα, Pparγ,* and *Eci1* in the liver
----------------------------------------------------------

[Figure 4](#f4-nmi-7-2014-029){ref-type="fig"} shows representative gel scans of the RT-PCR amplificates of the target genes in the liver of the five diet groups. The relative *Pparα* mRNA levels of the HZ-CBR and HZ-SFR groups were more than twice as high as those of the corresponding LZ group and the HZ-SF group fed free choice ([Table 3](#t3-nmi-7-2014-029){ref-type="table"}). *Pparγ* transcript levels did not significantly differ among the five diet groups. *Eci1*-mRNA abundance was not significantly affected by the dietary Zn level, but there was a 1.6-fold difference between the LZ-CB and the HZ-SF groups (*P* \< 0.05), suggesting a significant difference in response to the dietary fat source.

Discussion
==========

Zn status
---------

Depressed appetite and growth retardation are well-known early signs of alimentary Zn deficiency. Accordingly, the rats fed the LZ-CB and LZ-SF diets displayed markedly reduced food intakes as well as lower final body weights than those offered the HZ-SF diet free choice. There were, however, no conspicuous differences in the outer appearance of the animals other than body size. The deficient Zn status of the animals fed the LZ diets is clearly evident from the greatly reduced plasma and femur Zn concentrations relative to the values recorded for the animals consuming the HZ diets ([Table 2](#t2-nmi-7-2014-029){ref-type="table"}). In the LZ-SF group, final body weights and Zn concentrations in plasma and femur were markedly lower (26, 35, and 23%, respectively) than in the LZ-CB group despite the same dietary Zn level, indicating an effect of fat source. It may be argued that the LZ-CB diet was consumed in higher amounts than the LZ-SF diet because of a preference for the CB-containing diet. This possibility, however, is not supported by the following observations. First, an interaction between dietary Zn level and fat type has been observed previously.[@b22-nmi-7-2014-029] Food intake, growth rate, and plasma Zn concentrations of weanling rats fed moderately Zn-deficient diets were reduced to a greater extent when their diet was enriched with sunflower oil as compared with beef tallow, whereas these diets were consumed in comparable amounts, and growth rates were comparable when the dietary Zn content was high.[@b22-nmi-7-2014-029] In support, numerous previous studies did not find a differential intake among Zn-adequate, high-fat (≥15%) diets supplemented with saturated versus unsaturated fats.[@b22-nmi-7-2014-029],[@b26-nmi-7-2014-029]--[@b29-nmi-7-2014-029] Second, restriction of food intake per se does not lead to reduced plasma Zn concentrations. Plasma and femur Zn concentrations in the groups fed the HZ-SF diet either free choice or in restricted amounts were comparable ([Table 2](#t2-nmi-7-2014-029){ref-type="table"}). This agrees with former studies showing that plasma or serum Zn concentrations are not altered when Zn-adequate diets are fed in restricted amounts as compared with ad libitum feeding.[@b22-nmi-7-2014-029],[@b30-nmi-7-2014-029]--[@b33-nmi-7-2014-029] Finally, growth retardation because of an alimentary Zn deficit cannot be attributed to a loss of appetite as the primary cause. It has already been shown in 1970 that increasing the food intake of Zn-depleted young rats by force-feeding does not alleviate the growth arrest but instead quickly elicits severe signs of ill health and morbidity of the animals.[@b34-nmi-7-2014-029] Taken together, the evidence of the present study indicates a poorer Zn status of the rats fed the LZ-SF diet compared with those fed the LZ-CB diet despite comparable liver Zn concentrations, in agreement with previous studies.[@b22-nmi-7-2014-029],[@b35-nmi-7-2014-029] The underlying mechanism for this effect of fat source on Zn status awaits further research.

Gene expression and fatty acid metabolism
-----------------------------------------

Fatty acids are an important energy source for the liver. The expression of hepatic genes coding for proteins and key enzymes involved in fatty acid catabolism in the liver is mediated by PPARα, the major PPAR transcription factor in hepatocytes.[@b1-nmi-7-2014-029]--[@b3-nmi-7-2014-029] The expression of PPARα in the liver of rats and mice has been found to follow a diurnal rhythm.[@b36-nmi-7-2014-029]--[@b40-nmi-7-2014-029] Oishi et al[@b38-nmi-7-2014-029] show that this circadian expression of *Pparα* is regulated directly by clock genes and is abolished in homozygous *Clock* mutant mice. But food plays a dominant role as a zeitgeber for circadian oscillations of gene expression in the liver and other peripheral tissues (see below).[@b41-nmi-7-2014-029] *Pparα*-mRNA must be translated first into its protein counterpart before it can serve its role as nuclear transcription factor and ultimately transactivate its numerous target genes, including those involved in lipid metabolism. In the liver of rats, PPARα protein levels closely followed the diurnal cycling of *Pparα*-mRNA levels suggesting an efficient translation of its mRNA.[@b36-nmi-7-2014-029] Yang et al[@b42-nmi-7-2014-029] also reported corresponding increases in the expression of PPARα at both the transcript and protein levels in the liver of *Rheb1* null mice as a result of a pronounced decrease in food intake. These knockout mice exhibited increases in hepatic transcript levels of genes involved in β-oxidation and ketogenesis (including carnitine palmitoyltransferase 1A, medium-chain acyl-CoA dehydrogenase, and mitochondrial 3-hydroxy 3-methylglutaryl-CoA synthase), and markedly elevated serum levels of BHB concentrations compared with normal control mice. These findings reflect responses at all levels of cell function from gene transcription in the nucleus to hepatic fatty acid catabolism. Activation of the transcriptional activity of PPARs is a highly complex regulatory process that involves ligand binding, release of corepressors, and binding of the nuclear receptor RXR and diverse coactivators.[@b43-nmi-7-2014-029]--[@b45-nmi-7-2014-029] Recent studies suggest that natural ligands for PPARα in the liver are dietary and newly synthesized fatty acids,[@b46-nmi-7-2014-029],[@b47-nmi-7-2014-029] whereas plasma free fatty acids released by TAG lipolysis in adipose tissue activated hepatic PPARβ/δ.[@b48-nmi-7-2014-029] PPARα and PPARβ/δ presumably mediate the expression of similar target genes.[@b48-nmi-7-2014-029] The activated PPAR--RXR heterodimer binds to specific peroxisome-proliferator response elements (PPREs) of the target genes to initiate transcription. Functional PPREs have been identified for several of the targets of PPARα (including *Cpt1A, Acadl,* and *Hmgcs2*) but not for the auxiliary enzymes of UFA oxidation.[@b2-nmi-7-2014-029],[@b49-nmi-7-2014-029]

In our study, the relative transcript levels of the *Pparα* gene in the liver of the rats fed the HZ CB and SF diets in restricted amounts were about twice as high as those in the animals fed the corresponding LZ diets free choice. This marked effect, however, cannot be attributed to the difference in dietary Zn supply. The *Pparα*-mRNA levels of the ad libitum-fed LZ-CB and LZ-SF groups were comparable to the level of the ad libitum-fed HZ-SF group, clearly indicating that the moderate Zn deficiency of the animals fed the LZ diets did not impair *Pparα* transcription. We instead conclude that the higher *Pparα*-mRNA abundance in the HZ-CBR and -SFR groups is the consequence of the feeding protocol. Both short-term starvation[@b12-nmi-7-2014-029],[@b50-nmi-7-2014-029],[@b51-nmi-7-2014-029] and chronic food restriction[@b52-nmi-7-2014-029],[@b53-nmi-7-2014-029] have been shown to alter hepatic PPARα expression. In agreement with our experiment, hepatic *Pparα* transcript levels in rats exposed to a 85% food restriction (12-hour light--dark cycle, but without restriction in time of food access) were about twofold higher after a 12-hour fasting period than in control animals fed the same diet free choice.[@b53-nmi-7-2014-029] Regarding our study, it must be considered that the restricted food allocation in the HZ-CBR and HZ-SFR groups caused the animals to adapt to a daytime feeding pattern. These rats had almost completely consumed their daily ration by 23.30 hours when food was removed for a 10--12-hour overnight fasting period before sacrifice at the end of the experiment. At that time, the animals fed free choice had eaten at most half of the amount of food that they had consumed on the previous day, thus imposing an unaccustomed metabolic stress on these animals because of the lack of food during their habitual night-time feeding. There was no difference in food intake pattern between the animals offered the Zn-deficient CB and SF diets and those receiving the HZ-SF diet free choice, which agrees with previous observations.[@b54-nmi-7-2014-029] I n rodents, as nocturnal animals who consume most of their food during the dark hours under a 12-hour light--dark cycle*, Pparα*-mRNA abundance in the liver reaches peak levels toward the end of the light phase, when energy homeostasis relies on fatty acid degradation and possibly on ketogenesis and gluconeogenesis, whereas nadir values are recorded at the beginning of the light cycle.[@b36-nmi-7-2014-029]--[@b40-nmi-7-2014-029] This circadian rhythm has been shown to shift by approximately 12 hours when food access is restricted to daytime hours.[@b39-nmi-7-2014-029] Such a shift may have also occurred in the restrictedly fed rats of our study, and thus can explain the elevated *Pparα* transcript levels in these animals. This assumption is supported by plasma BHB concentrations ([Fig. 2](#f2-nmi-7-2014-029){ref-type="fig"}), which were approximately twofold higher in the ad libitum-fed rats than in the restrictedly fed animals, suggesting that the former animals were affected by the overnight food withdrawal to a greater extent than those accustomed to the habitual food shortage during the dark hours. Similarly, plasma ketone body concentrations after an overnight fast were about three times as high in Zn-deficient rats as in pair-fed control rats that had become meal eaters.[@b55-nmi-7-2014-029] Furthermore, rats that were continuously fed a Zn-supplemented diet showed much higher fasting plasma concentrations of free fatty acid than meal-eating rats.[@b56-nmi-7-2014-029]

Previous studies[@b15-nmi-7-2014-029],[@b16-nmi-7-2014-029] found that the transcription levels of *Pparα* and of genes coding for proteins involved in fatty acid degradation, including the *Eci1* gene, were markedly down-regulated in the liver of Zn-depleted young rats as compared with Zn-adequate control animals, whereas transcript levels of genes involved in de novo fatty acid synthesis were up-regulated along with increased hepatic TAG concentrations. These findings obviously conflict with our results, which indicate that the hepatic transcript levels of *Pparα* (*Pparγ* and *Eci1* as well) were not reduced in the rats fed the LZ-CB and LZ-SF diets as compared with the animals fed the HZ-SF diet free choice. Prominent differences between our and the former studies[@b15-nmi-7-2014-029],[@b16-nmi-7-2014-029] concern diet composition, in particular zinc, carbohydrate, and fat content; and the feeding protocol. First, it could be argued that the rats offered the LZ-CB and LZ-SF diets were exposed only to a moderate Zn deficit, allowing considerable growth rates. Second, fat contributed about 60% and carbohydrates (starch and sucrose) only about 22% of ME intake in our study. Hence, it is reasonable to assume that hepatic de novo fatty acid synthesis was greatly depressed in our experiment. In support, in weanling rats fed very similar high-fat, low-carbohydrate diets, the hepatic activity of glucose-6- phosphate dehydrogenase, which belongs to the lipogenic enzyme family and closely correlates with the rate of fatty acid synthesis in the liver,[@b57-nmi-7-2014-029] was greatly reduced as compared with animals fed a low-fat, high-carbohydrate diet.[@b22-nmi-7-2014-029] Third, the most decisive difference in the experimental protocols concerns the feeding regimen. In the former studies,[@b15-nmi-7-2014-029],[@b16-nmi-7-2014-029] the young rats were force-fed by intragastric tube to equalize the amount and frequency of intake of the Zn-deficient and Zn-supplemented diet. These diets were fed at a level (11.6 g dry matter/day) that exceeds amounts that Zn-depleted young rats have been observed to consume voluntarily,[@b58-nmi-7-2014-029] whereas the identical quantity of the Zn-adequate diet given to the control rats was evidently below the expected amount of free-choice intake and limited their weight gain to merely 2.4 g/d,[@b15-nmi-7-2014-029] a level that is about 40% below the gain (\~4 g/d) in the LZ-SF group of our experiment at a similar body weight. Force-feeding of severely Zn-deficient diets above appetite is likely to stimulate energy storage, because the deficit of zinc inhibits cell division, nitrogen retention, and lean tissue growth.[@b59-nmi-7-2014-029]--[@b61-nmi-7-2014-029] Hence, the metabolic response to forced overnutrition can be expected to induce lipogenesis and fatty livers, and induce a down-regulation of the transcription of *Pparα* and its target genes of the fatty acid oxidation pathway.[@b62-nmi-7-2014-029] In agreement with such a nutritional state, the livers of young rats force-fed Zn-deficient diets displayed markedly higher activities of lipogenic enzymes[@b63-nmi-7-2014-029] and increased triglyceride concentrations.[@b58-nmi-7-2014-029] In contrast, triglyceride concentrations in the liver of young rats offered Zn-deficient diets for voluntary consumption were not higher than in the liver of Zn-supplemented control animals fed ad libitum or restrictedly.[@b22-nmi-7-2014-029],[@b58-nmi-7-2014-029] In line with these former studies, hepatic TAG concentrations did not differ between the rats fed the LZ and HZ diets in our experiment ([Fig. 3](#f3-nmi-7-2014-029){ref-type="fig"}). On the other hand, chronic underfeeding is prone to enhance hepatic *Pparα* expression. In the liver of mice that were fed below appetite for seven days in a synchronized pair-feeding protocol (food access only during the 12-hour dark cycle before sacrifice the following morning), *Pparα*-mRNA abundance was more than threefold higher than in control animals receiving food ad libitum.[@b52-nmi-7-2014-029] Taken together, it may be presumed that the formerly observed marked difference in the transcription of *Pparα* and target genes encoding enzymes of fatty acid catabolism in the liver of force-fed Zn-deficient rats[@b15-nmi-7-2014-029],[@b16-nmi-7-2014-029] was not because of a deficit of zinc per se but instead was the consequence of feeding the Zn-deficient diet above and the Zn-supplemented diet below appetite of the animals, inducing metabolic states of over- and underfeeding, respectively.

Zinc is, beyond doubt, essential for the transcriptional activity of PPAR proteins. These nuclear transcription factors, and their heterodimeric binding partner RXR as well, contain Zn finger structures in their DNA-binding domain, which are critical for the polarity and specificity of the receptor element binding.[@b10-nmi-7-2014-029],[@b11-nmi-7-2014-029] The DNA-binding activity of PPARα and PPARγ proteins has been found to be impaired in cultures of Zn-deprived porcine vascular cells, and PPAR agonists could induce PPAR-binding activity only in Zn-sufficient cells.[@b64-nmi-7-2014-029] Furthermore, the DNA-binding activity of PPARγ was significantly reduced in the liver of Zn-deficient mice.[@b21-nmi-7-2014-029] The pivotal role of PPARα-mediated transcription of genes coding for proteins and enzymes involved in fat catabolism is clearly evident from studies with *Pparα*-null mice, which develop hypoglycemia, hypoketonemia, and fatty livers when they are exposed to starvation because of their inability to increase hepatic fatty acid oxidation and ketogenesis.[@b12-nmi-7-2014-029]--[@b14-nmi-7-2014-029] Similar metabolic symptoms have been observed in *Eci1*-deficient mice.[@b65-nmi-7-2014-029] *Eci1* and *Hmgc*s*2*, the latter coding for the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase, the rate-limiting enzyme in the hepatic synthesis of ketone bodies, are among the genes that are regulated by PPARα.[@b2-nmi-7-2014-029],[@b14-nmi-7-2014-029],[@b49-nmi-7-2014-029],[@b66-nmi-7-2014-029] In consideration of these metabolic findings, it can be hypothesized that an impaired transcriptional activity of the PPARα protein toward its target genes because of a deficit of zinc should adversely affect fatty acid oxidation and ketogenesis in the liver, especially when fat is the preponderant source of energy and the intake of available carbohydrates is low as it was the case in our study. However, the metabolic evidence available from our experiment and that from previous research indicates that alimentary Zn deficiency does not compromise mitochondrial fatty acid degradation and ketogenesis. In our experiment, the hepatic *Eci1*-mRNA levels did not differ between the rats fed the LZ and HZ diets. This indirectly suggests that the activity of PPARα as nuclear transcription factor was not impaired by the mild Zn deficiency. Furthermore, plasma BHB concentrations after the overnight fasting period were comparable among the ad libitum-fed animals independent of the dietary Zn supply. In previous studies, severe Zn deficiency did not adversely affect fatty acid oxidation or ketogenesis. As early as in 1966, Theuer and Hoekstra[@b67-nmi-7-2014-029] reported that the oxidation of ^14^C-labeled palmitic acid administered to severely Zn-deficient weanling rats 14 hours after food withdrawal was not impaired as compared with Zn-adequate control animals. Also, the extent of β-oxidation of linoleic and α-linolenic acid, and serum BHB concentrations were higher in Zn-deficient pregnant and nonpregnant rats than in Zn-adequate control animals.[@b68-nmi-7-2014-029],[@b69-nmi-7-2014-029] Fasting plasma ketone body concentrations in Zn-depleted young rats were about three times as high as in Zn-supplemented pair-fed animals.[@b55-nmi-7-2014-029] Plasma BHB concentrations and oxidation of BHB in pregnant rats given a suboptimal zinc diet (6 μg Zn/g diet) were markedly higher than in Zn-sufficient controls.[@b70-nmi-7-2014-029] Both groups were in a negative energy balance because of the late stage of pregnancy, but there was no evidence of maternal hypoglycemia. Thus, our study is consistent with these former studies suggesting that zinc is not a critical nutrient in β-oxidation of fatty acids and ketogenesis.

In our experiment, the SF diet did not induce higher *Pparα*-mRNA levels than the CB diet despite a more than twofold higher intake of unsaturated fatty acids (predominantly linoleic acid). This finding agrees with previous studies showing that the transcription of the *Pparα* gene itself is much less responsive to the type of fatty acid intake than the transcriptional activity of the PPARα protein on its target genes.[@b47-nmi-7-2014-029],[@b71-nmi-7-2014-029],[@b72-nmi-7-2014-029] Remarkably, *Eci1*-mRNA levels were not related to *Pparα*-mRNA levels *(r* = 0.20, *P* \> 0.05). Overall, the former were higher in the liver of the SF-fed animals, especially in the HZ-SF group (*P* \< 0.05), than in the CB-fed groups, suggesting a moderate response to the dietary fat source. This agrees with previous studies reporting that rodents fed diets enriched with linoleic acid as compared with saturated fatty acids displayed elevated *Eci1* transcript levels, even though the differences were not significant.[@b73-nmi-7-2014-029]--[@b75-nmi-7-2014-029]

In conclusion, the moderate Zn deficiency did not impair gene expression of *Pparα, Pparγ,* and *Eci1* in the liver of weanling rats fed fat-enriched diets, in which CB and SF oil were the preponderant energy source (about 60% of the dietary ME). The observed elevated abundance of *Pparα-*mRNA in the restrictedly fed animals corroborates a sensitive response to changes in the feeding regimen. There was a notable increase in the hepatic *Eci1* transcription in response to the SF oil-based diets. Plasma BHB levels suggest that β-oxidation of fatty acids and ketogenesis was not affected by the moderate Zn deficiency.
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![Mean body weights of weanling rats fed different diets for four weeks.\
**Notes:** Final body weights (week 4): significance of difference among diet groups by one-way ANOVA, *P* \< 0.001; pooled SEM = 4.9 g; a, b, c, mean values not sharing common letter significantly differ (*P* \< 0.05; Tukey test).\
**Feeding protocol:** LZ-CB, fed the LZ diet (7 mg Zn/kg) with 22% CB free choice; HZ-CBR, fed the HZ diet (50 mg Zn/kg) with 22% CB in restricted amounts according to intake in the LZ-CB group; LZ-SF, fed the LZ diet with 22% SF oil free choice; HZ-SFR, fed the HZ diet with 22% SF oil in restricted amounts according to intake in the LZ-SF group; and HZ-SF, fed the HZ diet with 22% SF oil free choice.](nmi-7-2014-029f1){#f1-nmi-7-2014-029}

![Plasma BHB concentrations of weanling rats fed different diets for four weeks.\
**Notes:** Plasma was obtained after an overnight food withdrawal for 10--12 hours (see the Methods and Materials section). Significance of difference among diet groups by one-way ANOVA, *P* \< 0.001. error bars represent ± SEM (*n* = 5); a, b, means not sharing common letter significantly differ (*P* \< 0.05; Tukey test after logarithmic transformation).\
**Feeding protocol:** LZ-CB, fed the LZ diet (7 mg/kg diet) with 22% CB free choice; HZ-CBR, fed the HZ diet (50 mg/kg) with 22% CB in restricted amounts according to intake in the LZ-CB group; LZ-SF, fed the LZ diet with 22% SF oil free choice; HZ-SFR, fed the HZ diet with 22% SF oil in restricted amounts according to intake in the LZ-SF group; and HZ-SF, fed the LZ diet with 22% SF oil free choice.](nmi-7-2014-029f2){#f2-nmi-7-2014-029}

![Triglyceride (TAG) concentrations in the liver of weanling rats fed different diets for four weeks.\
**Notes:** Significance of difference among diet groups by one-way ANOVA, *P* \< 0.001. Error bars represent ± SEM (*n =* 8); a, b, means not sharing common letter significantly differ (*P* \< 0.05; Tukey test).\
**Feeding protocol:** LZ-CB, fed the LZ diet (7 mg Zn/kg) with 22% CB free choice; HZ-CBR, fed the HZ diet (50 mg Zn/kg) with 22% CB in restricted amounts according to intake in the LZ-CB group; LZ-SF, fed the LZ diet with 22% SF oil free choice; HZ-SFR, fed the HZ diet with 22% SF oil in restricted amounts according to intake in the LZ-SF group; and HZ-SF, fed the LZ diet with 22% SF oil free choice.](nmi-7-2014-029f3){#f3-nmi-7-2014-029}

![Ethidium bromide fluorescence of the RT-PCR amplificates: (**A**) *Pparα* (test kit A) and *Pparγ* (test kit B), (**B**) *Eci1* (test kit A), and (**C**) *Eci1* (test kit B) together with the respective scans of *Gapdh* (see Analytical Methods section).\
**Feeding protocol:** LZ-CB, fed the LZ diet (7 mg Zn/kg) with 22% CB free choice; HZ-CBR, fed the HZ diet (50 mg Zn/kg) with 22% CB in restricted amounts according to intake in the LZ-CB group; LZ-SF, fed the LZ diet with 22% SF oil free choice; HZ-SFR, fed the HZ diet with 22% SF oil in restricted amounts according to intake in the LZ-SF group; and HZ-SF, fed the LZ diet with 22% SF oil free choice.](nmi-7-2014-029f4){#f4-nmi-7-2014-029}

###### 

Composition of the experimental diets.

  INGREDIENT                                                     (g/kg)
  -------------------------------------------------------------- --------
  Egg albumen powder                                             200
  Corn starch                                                    67
  Sucrose                                                        100
  Cellulose                                                      280
  Soybean oil                                                    30
  *L*-Lysine + *L*-methionine (1:1)                              3
  Mineral mix[\*](#tfn1-nmi-7-2014-029){ref-type="table-fn"}     70
  Vitamin premix[†](#tfn2-nmi-7-2014-029){ref-type="table-fn"}   10
  Zinc premix[‡](#tfn3-nmi-7-2014-029){ref-type="table-fn"}      20
  Fat supplement[¶](#tfn4-nmi-7-2014-029){ref-type="table-fn"}   220
  **Sum**                                                        1000

**Notes:**

Mineral mix (per kilogram diet): 17.88 g CaHPO~4~ × 2H~2~O, 10.02 g KH~2~PO~4~, 6.08 MgSO~4~ × 7H~2~O, 6.44 g CaCO~3~, 1.65 g NaCl, 0.81 g Na~2~CO~3~, 248.9 mg FeSO~4~ × 7H~2~O, 76.9 mg MnSO~4~ × H~2~O, 31.4 mg CuSO~4~ × 5H~2~O, 9.6 mg KCr(SO~4~)~2~ × 12H~2~O, 2.4 mg CoSO~4~ × 7H~2~O, 2.2 mg NaF, 0.8 mg Na~2~SeO~3~ × 5H~2~O, 0.5 mg KI, 0.5 mg Na~2~MoO~4~ × 2H~2~O, and corn starch ad 70 g.

Vitamin premix (per kilogram diet): 1.80 mg *all trans* retinol, 27.5 μg cholecalciferol; 40 mg *RRR*-α-tocopheryl acetate, 5.0 mg menadione; 6.0 mg thiamin HCl, 8.0 mg riboflavin, 2.4 mg folic acid, 40 mg niacin, 30 mg Ca-pantothenate, 10.0 mg pyridoxine, 0.1 mg cobalamin, 100 mg ascorbic acid, 2.0 mg d*-*biotin, 1,100 mg choline chloride, 100 mg *myo*-inositol, and corn starch ad 10 g.

Zinc premix (per kilogram diet): LZ diets, 30.8 mg ZnSO~4~ × 7H~2~O, corn starch ad 20 g; HZ diets, 219.9 mg ZnSO~4~ × 7H~2~O, corn starch ad 20 g.

Cocoa butter (CB) or safflower (SF) oil.

###### 

Zinc concentrations in plasma, femur, and liver of weanling rats fed different diets for four weeks.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  DIET GROUP                                                    PLASMA Zn\                                            FEMUR Zn\                                                                                        LIVER Zn\
                                                                (μg/mL)                                               (μg/g FRESH WT)                                                                                  (μg/g FRESH WT)
  ------------------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------------------------------------------ ----------------------------------------------------
  LZ-CB                                                         0.97[b](#tfn5-nmi-7-2014-029){ref-type="table-fn"}    51[b](#tfn5-nmi-7-2014-029){ref-type="table-fn"}                                                 27.7[a](#tfn5-nmi-7-2014-029){ref-type="table-fn"}

  HZ-CBR                                                        1.41[d](#tfn5-nmi-7-2014-029){ref-type="table-fn"}    137[d](#tfn5-nmi-7-2014-029){ref-type="table-fn"}                                                29.8[a](#tfn5-nmi-7-2014-029){ref-type="table-fn"}

  LZ-SF                                                         0.63[a](#tfn5-nmi-7-2014-029){ref-type="table-fn"}    39[a](#tfn5-nmi-7-2014-029){ref-type="table-fn"}[†](#tfn6-nmi-7-2014-029){ref-type="table-fn"}   27.3[a](#tfn5-nmi-7-2014-029){ref-type="table-fn"}

  HZ-SFR                                                        1.18[c](#tfn5-nmi-7-2014-029){ref-type="table-fn"}    123[c](#tfn5-nmi-7-2014-029){ref-type="table-fn"}                                                28.2[a](#tfn5-nmi-7-2014-029){ref-type="table-fn"}

  HZ-SF                                                         1.08[bc](#tfn5-nmi-7-2014-029){ref-type="table-fn"}   127[cd](#tfn5-nmi-7-2014-029){ref-type="table-fn"}                                               29.2[a](#tfn5-nmi-7-2014-029){ref-type="table-fn"}

  **SEM**[‡](#tfn7-nmi-7-2014-029){ref-type="table-fn"}         0.036                                                 2.5                                                                                              0.87

  ***P* value[¶](#tfn8-nmi-7-2014-029){ref-type="table-fn"}**   \<0.001                                               \<0.001                                                                                          0.258
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

Means (*n* = 8) not sharing common superscript letters within columns significantly differ (*P* \< 0.05; Tukey test).

*n* = 7.

Pooled standard error of the mean.

Significance of difference among diet groups by one-way ANOVA.

LZ-CB, fed the LZ diet (7 mg Zn/kg) with 22% CB free choice; HZ-CBR, fed the HZ diet (50 mg Zn/kg) with 22% CB in restricted amounts according to intake in the LZ-CB group; LZ-SF, fed the LZ diet with 22% SF oil free choice; HZ-SFR, fed the HZ diet with 22% SF oil in restricted amounts according to intake in the LZ-SF group; and HZ-SF, fed the HZ diet with 22% SF oil free choice.

###### 

Relative mRNA expression of *Pparα*, *Pparγ*, and mitochondrial Δ^3^, Δ^2^-enoyl-CoA-isomerase (*Eci1*) in the liver of weanling rats fed different diets for four weeks (combined analysis of two test kits; see the Analytical Methods section).

  DIET GROUP                                                    *Pparα*                                               *Pparγ*                                               *Eci1*
  ------------------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------
  LZ-CB[\*](#tfn11-nmi-7-2014-029){ref-type="table-fn"}         1.00[a](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.00[a](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.00[a](#tfn10-nmi-7-2014-029){ref-type="table-fn"}
  HZ-CBR                                                        2.25[b](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.47[a](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.31[ab](#tfn10-nmi-7-2014-029){ref-type="table-fn"}
  LZ-SF                                                         1.24[a](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.52[a](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.40[ab](#tfn10-nmi-7-2014-029){ref-type="table-fn"}
  HZ-SFR                                                        2.68[b](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.52[a](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.36[ab](#tfn10-nmi-7-2014-029){ref-type="table-fn"}
  HZ-SF                                                         1.24[a](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.55[a](#tfn10-nmi-7-2014-029){ref-type="table-fn"}   1.60[b](#tfn10-nmi-7-2014-029){ref-type="table-fn"}
  **SEM**[†](#tfn12-nmi-7-2014-029){ref-type="table-fn"}        0.144                                                 0.273                                                 0.116
  ***P*value**[‡](#tfn13-nmi-7-2014-029){ref-type="table-fn"}   \<0.001                                               0.599                                                 0.050

**Notes:** Means (*n* = 3) not sharing common superscript letters within columns significantly differ (*P* \< 0.05; Tukey test).

Lowest group mean value within group = 1.

Pooled standard error of the mean.

Significance of difference among diet groups by one-way ANOVA.

LZ-CB, fed the LZ diet (7 mg Zn/kg) with 22% CB free choice; HZ-CBR, fed the HZ diet (50 mg Zn/kg) with 22% CB in restricted amounts according to intake in the LZ-CB group; LZ-SF, fed the LZ diet with 22% SF oil free choice; HZ-SFR, fed the HZ diet with 22% SF oil in restricted amounts according to intake in the LZ-SF group; and HZ-SF, fed the HZ diet with 22% SF oil free choice.
